Sat.Nov 07, 2020

article thumbnail

Radio IQ’s Mallory Noe-Payne receives Fulbright journalist grant

Scienmag

Credit: Virginia Tech Radio IQ Richmond Bureau Chief Mallory Noe-Payne has received a Fulbright Young Professional Journalist Grant. The grant allows for Noe-Payne to travel to Germany for a 10-month residency to research and examine the history of that nation and the United States of America. Noe-Payne will engage in a project titled “Memory Wars: […].

article thumbnail

Investigators Discover Unique Immune Cells in Patients with Checkpoint Inhibitor-Induced Arthritis

The Pharma Data

NEW YORK , Nov. 8, 2020 /PRNewswire/ — Since doctors began treating cancer patients with immunotherapy drugs called checkpoint inhibitors nearly a decade ago, they have observed that a subset of these patients experience a side effect that clinically looks like inflammatory arthritis. These drugs, which take the natural brake off immune cells called T cells and allow them to attack cancer, can result in T cells also attacking healthy tissues, including the joints.

Nurses 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Using machine learning to track the pandemic’s impact on mental health

Scienmag

Textual analysis of social media posts finds users’ anxiety and suicide-risk levels are rising, among other negative trends CAMBRIDGE, MA — Dealing with a global pandemic has taken a toll on the mental health of millions of people. A team of MIT and Harvard University researchers has shown that they can measure those effects by […].

article thumbnail

Improving the Diagnosis of Chronic Nonbacterial Osteomyelitis, an Underdiagnosed Chronic Autoinflammatory Syndrome

The Pharma Data

NEW YORK , Nov. 8, 2020 /PRNewswire/ — Researchers have identified several factors that should help improve the diagnosis of chronic nonbacterial osteomyelitis (CNO), also known as chronic recurrent multifocal osteomyelitis (CRMO). This chronic autoinflammatory syndrome, which can be debilitating, is underdiagnosed and is characterized by multiple foci of painful swelling of bones, mainly in the metaphyses of the long bones, in addition to the pelvis, the shoulder girdle and the spine.

Nurses 52
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

New tentative approval for Gland Pharma drug tirofiban hydrochloride

Drug Patent Watch

Tirofiban hydrochloride is the generic ingredient in one branded drug marketed by Medicure and is included in two NDAs. There is one patent protecting this compound. Drug patent litigation for…. The post New tentative approval for Gland Pharma drug tirofiban hydrochloride appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 40
article thumbnail

Statement from the Chief Public Health Officer of Canada on November 8, 2020

The Pharma Data

OTTAWA, ON , Nov. 8, 2020 /CNW/ – In lieu of an in-person update to the media, Dr. Theresa Tam , Canada’s Chief Public Health Officer, issued the following statement today: “As the resurgence of COVID-19 activity continues in Canada , we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

40

More Trending

article thumbnail

Aptevo Therapeutics Adopts Limited Duration Stockholder Rights Plan

The Pharma Data

SEATTLE, WA / ACCESSWIRE / November 8, 2020 / Aptevo Therapeutics Inc. (“Aptevo”) (NASDAQ:APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR bispecific technology platform, today announced that its Board of Directors has approved the adoption of a limited duration stockholder rights plan and declared a dividend distribution of one right for each outstanding share of common stock.

article thumbnail

Drug Patent Expirations for the Week of November 8, 2020

Drug Patent Watch

DILAUDID-HP (hydromorphone hydrochloride) Fresenius kabi usa Patent: 6,589,960 Expiration: Nov 9, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…. The post Drug Patent Expirations for the Week of November 8, 2020 appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 40
article thumbnail

Shockwave IVL Is Superior to Angioplasty in Severely Calcified Peripheral Artery Disease

BioTech 365

Shockwave IVL Is Superior to Angioplasty in Severely Calcified Peripheral Artery Disease Shockwave IVL Is Superior to Angioplasty in Severely Calcified Peripheral Artery Disease Disrupt PAD III is Largest Randomized Study of Complex Patients Typically Excluded from Clinical Trials SANTA … Continue reading →

article thumbnail

When Your Spouse Gripes About Aging, It Might Harm Your Health

The Pharma Data

SATURDAY, Nov. 7, 2020 — In older couples, one spouse’s negative thoughts about aging can affect the other spouse’s health, a new study indicates. It also found that these effects differ by gender. A wife’s views about aging are linked with her husband’s physical health, while a husband’s view about aging are associated with his wife’s mental health.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Four-year results from patient-level meta-analysis confirm safety profile of Philips Stellarex.035” low-dose drug-coated balloon

BioTech 365

Four-year results from patient-level meta-analysis confirm safety profile of Philips Stellarex.035” low-dose drug-coated balloon Four-year results from patient-level meta-analysis confirm safety profile of Philips Stellarex.

Drugs 40
article thumbnail

Which pharmaceutical companies have the most SPCs in Luxembourg?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Luxembourg. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Luxembourg? appeared first on DrugPatentWatch - Make Better Decisions.

40